Vaccines currently available to the global market are Bavarian Nordic’s MVA-BN (JYNNEOS), KM Biologics’ LC16, and Emergent ...

This research could expand access to Bavarian Nordic’s MVA-BN mpox vaccine, currently the only WHO prequalified vaccine for healthy adults and adolescents, to include these vulnerable populations.

THURSDAY, Oct. 17, 2024 (HealthDay News) -- The Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine, licensed in the United States to prevent smallpox and mpox, is well tolerated and seems ...

Pregnant women and infants are at risk should they contract mpox but there are no approved vaccines for this population.

The World Health Organisation and the Africa Centres for Disease Control and Prevention have committed to guiding the ...

The World Health Organisation and the Africa Centre for Disease Control and Prevention experts have decided to provide ...

Kenya is among nine countries in Africa that have been allocated MPOX vaccine doses, following an MPOX surge in the continent ...

Nineteen African states—those currently reporting or that have reported Mpox cases within this outbreak—gathered in a ‘back-to-school’ style meeting in Congo Brazzaville in the first week of November.

Results from this study could support an extension of the current approval of MVA-BN to include children from 2 years of age ...

An initial 899,000 vaccine doses have been allocated to Nigeria and 8 other countries across Africa that have been hit ...

“Both organisations made concerted efforts to help countries acquire vaccines amid ongoing outbreaks. WHO added the MVA-BN vaccine to its prequalification list on September 13, 2024, and established ...

Both organizations have made concerted efforts to help countries acquire vaccines amid ongoing outbreaks. WHO added the ...